ConductScience.org, home

Library / Genes

KAT2B: lysine acetyltransferase 2B

1 protein, 36 patents, 0 drugs, 0 trials, 4,030 NIH grants and 6,211 papers.

Gene 7

Its symbol and name are HGNC's, unless HGNC and NCBI Gene contradict each other.

FieldValueSource
SymbolKAT2BHGNC
Namelysine acetyltransferase 2BHGNC
NCBI Gene ID8850NCBI Gene
HGNC IDHGNC:8638HGNC
EnsemblENSG00000114166NCBI Gene
AliasesCAF, GCN5, GCN5L, P/CAF, PCAFNCBI Gene
Typeprotein-codingNCBI Gene

Proteins 1

Reviewed human proteins whose Swiss-Prot entry states the gene.

UniProt entryProteinLengthStructuresGene stated inSource
Q92831Histone acetyltransferase KAT2B83225Ensembl, GeneID, HGNCUniProt

Patents 36

Patents whose sequence listing holds the protein exactly: the same sequence, by SHA-256, length and CRC-64. A sequence a patent lists is not always one it claims.

PublicationPublishedSEQ ID NOProteinSource
JP 2025172069 A2025-11-20719Q92831Espacenet
EP 4650780 A22025-11-192251Q92831Espacenet
EP 4641201 A22025-10-291820Q92831Espacenet
JP 2025517969 A2025-06-121820Q92831Espacenet
JP 2025517970 A2025-06-122251Q92831Espacenet
US 12247982 B22025-03-11719Q92831Espacenet
JP 2023113918 A2023-08-16719Q92831Espacenet
US 11564998 B22023-01-314938Q92831Espacenet
US 11446398 B22022-09-2042401Q92831Espacenet
JP 2022524081 A2022-04-27145372Q92831Espacenet

Drugs 0

Drugs a ChEMBL mechanism record says act on the gene's protein, through Open Targets.

DrugChEMBL IDMechanismActionSource

Trials 0

Trials of those drugs. A trial joins the gene only through a drug that acts on it.

TrialDrugPhaseResults first postedSource

NIH grants 4030

NIH projects whose papers are about the gene, through NIH's grant-paper links.

ProjectTitleIts papers about the geneNewest fiscal yearSource
P30CA016672Cancer Center Support Grant372,025NIH's project files
P30CA008748Cancer Center Support Grant212,025NIH's project files
P30CA010815Consolidated Basic Cancer Research Program132,025NIH's project files
P30AI027763UCSF-Bay Area Center for AIDS Research122,025NIH's project files
P30CA076292Moffitt Cancer Center Support Grant112,025NIH's project files
ZIABC011488Targeting Cancer Through Modifications and Metabolism112,025NIH's project files
P30DK084567Mayo Center for Cell Signaling in Gastroenterology102,025NIH's project files
P30CA015083Mayo Clinic Comprehensive Cancer Center Support Grant92,025NIH's project files
P30CA125123Baylor College of Medicine Cancer Center - Cancer Center Support Grant92,025NIH's project files
P30CA016056Roswell Park Cancer Center Support Grant82,025NIH's project files

Papers 6211

Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.

PMIDFound bySource
42810632PubTator, text miningPubMed
42793094PubTator, text miningPubMed
42769056PubTator, text miningPubMed
42767388PubTator, text miningPubMed
42742903PubTator, text miningPubMed
42716139PubTator, text miningPubMed
42710127PubTator, text miningPubMed
42709345PubTator, text miningPubMed
42700784PubTator, text miningPubMed
42669119PubTator, text miningPubMed

The same record as JSON

Release gene-search-2026-11-11-0.1.0

ClinicalTrials.gov's posted results, through CTTI's AACT: ClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299 ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

ChEMBL, through Open Targets: CC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence

ClinicalTrials.gov: none stated ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

EMBL-EBI's patent proteins: EMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use

GenBank's patent files: GenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/

HGNC: CC0: https://www.genenames.org/about/license/

NCBI Gene: None named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/

NIH's project files and grant-paper links: Public domain (NIH RePORTER)

Open Targets: CC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence

PubTator 3: Public domain

UniProt: CC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license